López T, Almirall J, Calvet X, Quesada M, Sanfeliú I, Segura F, García M
Servicio de Nefrología, Hospital de Sabadell, Institut Universitari Parc Tauli/UAB, Parc Tauli s/n, 08208 Sabadell, Barcelona.
Nefrologia. 2006;26(6):673-8.
Many studies in the general population have shown a link between Helicobacter pylori infection and iron-deficiency, often resulting in iron-deficient anaemia. Despite the high prevalence of iron deficiency in hemodialysis patients, no studies have been performed in this population.
To evaluate the role of Helicobacter pylori infection in the appearance of anemia and the iron requirements in our hemodialysis population.
After excluding patients with severe pathology and short life expectancy and those with blood losses secondary to other causes, 79 patients were included.Iron requirements and anaemia were determined by iron serum, ferritin, and hematocrit values; and by transfusion, eritropoietin and iron requirements. The diagnosis of Helicobacter pylori status was established by the concordance of at least two of the three non invasive diagnostic methods performed (breath test, serology and fecal antigen of Helicobacter pylori).
Prevalence of Helicobacter pylori infection was 43%. No significant differences between patients infected or not by Helicobacter pylori were found in any of the variables analysed: hematocrit (33.5% versus 34.1%), serum iron (58.9 versus 63.7 pg/dl), ferritin(340.3 versus 264.2 ng/ml), transferrin saturation index (22.5% versus 25.2%), dose of eritropoietin administered (96.6 versus 93.5 U/kg/weekly), and parenteral iron (1,389 versus 1,538 mg/year). A noteworthy finding was that patients with Helicobacter pylori infection had been on hemodialysis for a shorter period than those without (37.4 versus 63.7 months,p = 0.04).
Helicobacter pylori infection has no effect on anaemia (hematocrit, Eritropoietin dose or iron needs) in our hemodialysis patients. Prevalence of Helicobacter pylori is lower in patients with longer time on dialysis. We consider that the diagnosis of Helicobacter pylori infection must be reserved for clinical peptic ulcer suspicion or patients on transplant waiting list.
普通人群中的许多研究表明幽门螺杆菌感染与缺铁之间存在关联,常导致缺铁性贫血。尽管血液透析患者缺铁的患病率很高,但尚未在该人群中开展相关研究。
评估幽门螺杆菌感染在我们血液透析人群贫血发生及铁需求方面的作用。
排除患有严重疾病、预期寿命短以及因其他原因导致失血的患者后,纳入79例患者。通过血清铁、铁蛋白和血细胞比容值,以及输血、促红细胞生成素和铁需求情况来确定铁需求和贫血情况。幽门螺杆菌感染状态的诊断通过三种非侵入性诊断方法(呼气试验、血清学检测和幽门螺杆菌粪便抗原检测)中至少两种结果的一致性来确定。
幽门螺杆菌感染率为43%。在分析的任何变量中,感染或未感染幽门螺杆菌的患者之间均未发现显著差异:血细胞比容(33.5%对34.1%)、血清铁(58.9对63.7 pg/dl)、铁蛋白(340.3对264.2 ng/ml)、转铁蛋白饱和度指数(22.5%对25.2%)、促红细胞生成素给药剂量(96.6对93.5 U/kg/周)以及静脉铁剂(1389对1538 mg/年)。一个值得注意的发现是,感染幽门螺杆菌的患者血液透析时间比未感染者短(37.4对63.7个月,p = 0.04)。
幽门螺杆菌感染对我们血液透析患者的贫血(血细胞比容、促红细胞生成素剂量或铁需求)没有影响。透析时间较长的患者幽门螺杆菌感染率较低。我们认为,幽门螺杆菌感染的诊断应仅用于临床怀疑消化性溃疡的患者或等待移植的患者。